The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.EBI
Ehime University
Diacylglycerol lactones targeting the structural features that distinguish the atypical C1 domains of protein kinase C¿ and¿ from typical C1 domains.EBI
National Cancer Institute-Bethesda
Structural basis of binding of high-affinity ligands to protein kinase C: prediction of the binding modes through a new molecular dynamics method and evaluation by site-directed mutagenesis.EBI
Georgetown University Medical Center
Conformationally constrained analogues of diacylglycerol (DAG). 28. DAG-dioxolanones reveal a new additional interaction site in the C1b domain of PKC delta.EBI
National Cancer Institute-Frederick
New bivalent PKC ligands linked by a carbon spacer: enhancement in binding affinity.EBI
Georgetown University Medical Center
Synthesis and biological activities of simplified aplysiatoxin analogs focused on the CH/? interaction.EBI
Kyoto University
Structural basis of RasGRP binding to high-affinity PKC ligands.EBI
Georgetown University Medical Center
Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations.EBI
Georgetown University Medical Center